The therapeutic effects of Irsogladine Maleate combined with triple therapy in Helicobacter pylori infective mice

du xiaoman,cheng hong,liu jianxiang,wang huahong,li jiang,hu fulian
DOI: https://doi.org/10.3969/j.issn.1006-5709.2017.06.009
2017-01-01
Abstract:Objective To observe the eradication effects of Irsogladine Maleate( IM) in Helicobacter pylori( H. pylori) infective mice and the influence on gastric mucosal inflammation. Methods Sixty KM mice were randomly divided into 6 groups,including blank control group,H. pylori infective control group and 4 treatment groups. The treatment groups were given standard triple therapy,bismuth-based quadruple therapy,low-dose IM + standard triple therapy and high-dose IM + standard triple therapy,respectively. After sacrifice,rapid urease tests( RUT) combined with pathological Giemsa staining were used to demonstrate eradication rate of H. pylori. HE staining of gastric mucosal was used to survey the inflammatory status. Results The eradication rates of bismuth-based quadruple therapy,low-dose IM +standard triple group and high-dose IM + standard triple group were 80. 0%,higher than standard triple group( 70. 0%),the eradication rate of H. pylori in 4 treatment groups had no significant difference( P > 0. 05). Repair effect of chronic inflammatory reaction of gastric mucosa of high-dose IM + standard triple therapy group was similar to the bismuth-based quadruple therapy,and better than standard triple therapy group,there was significantly different( P < 0. 05). Conclusion IM + standard triple therapy can reach the same eradication rate compared with bismuth-based quadruple therapy,with a tendency of higher than triple therapy. IM + standard triple group can significantly improve the chronic inflammatory reaction of gastric mucosa after eradication of H. pylori infection,with a dose dependent manner.
What problem does this paper attempt to address?